NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer

被引：0
|
作者：
Meng Ren
Hongyu Zhao
Yan Gao
Qi Chen
Xiaoting Zhao
Wentao Yue
机构：
[1] Capital Medical University,Central Laboratory, Beijing Obstetrics and Gynecology Hospital
[2] Beijing Maternal and Child Health Care Hospital,undefined
[3] Center for Discovery and Innovation,undefined
[4] Hackensack Meridian Health,undefined
来源：
Journal of Ovarian Research | / 16卷
关键词：
NUF2; Ovarian cancer; HNRNPA2B1; PI3K/AKT/mTOR signaling pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer
    Ren, Meng
    Zhao, Hongyu
    Gao, Yan
    Chen, Qi
    Zhao, Xiaoting
    Yue, Wentao
    JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
  • [2] PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway
    Elsayed, Abdelrahman M.
    Bayraktar, Emine
    Amero, Paola
    Salama, Salama A.
    Abdelaziz, Abdelaziz H.
    Ismail, Raed S.
    Zhang, Xinna
    Ivan, Cristina
    Sood, Anil K.
    Lopez-Berestein, Gabriel
    Rodriguez-Aguayo, Cristian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 25
  • [3] hnRNPA2B1 Promotes Colon Cancer Progression via the MAPK Pathway
    Tang, Jingzhi
    Chen, Zhimin
    Wang, Qi
    Hao, Weijie
    Gao, Wei-Qiang
    Xu, Huiming
    FRONTIERS IN GENETICS, 2021, 12
  • [4] Targeting the PI3K/AKT/mTOR pathway in ovarian cancer
    Musa, Fernanda
    Schneider, Robert
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (01) : 97 - 106
  • [5] The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
    Mabuchi, Seiji
    Kuroda, Hiromasa
    Takahashi, Ryoko
    Sasano, Tomoyuki
    GYNECOLOGIC ONCOLOGY, 2015, 137 (01) : 173 - 179
  • [6] The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
    Dobbin, Zachary C.
    Landen, Charles N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (04): : 8213 - 8227
  • [7] The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges
    Cheaib, Bianca
    Auguste, Aurelie
    Leary, Alexandra
    CHINESE JOURNAL OF CANCER, 2015, 34 (01) : 4 - 16
  • [8] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    Li, HaiXia
    Zeng, JianFang
    Shen, Keng
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (06) : 1067 - 1078
  • [9] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    HaiXia Li
    JianFang Zeng
    Keng Shen
    Archives of Gynecology and Obstetrics, 2014, 290 : 1067 - 1078
  • [10] CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway
    Shen, Fan
    Zong, Zhi-hong
    Liu, Yao
    Chen, Shuo
    Sheng, Xiu-jie
    Zhao, Yang
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
12345